Trial no.:
|
PACTR202111620456298 |
Date of Approval:
|
17/11/2021 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Comparative Study between Intravenous and Intraperitoneal Magnesium Sulphate for Pain Management in Laparoscopic mini gastric bypass
|
Official scientific title |
Comparative Study between Intravenous and Intraperitoneal Magnesium Sulphate for Pain Management in Laparoscopic mini gastric bypass
|
Brief summary describing the background
and objectives of the trial
|
Background:
Obesity is a widespread and growing condition with a significant impact on all aspects of healthcare including perioperative care. The frequency of bariatric surgery has been increasing worldwide for patients with medically complicated obesity .
Laparoscopic bariatric surgeries are now more popular than older open ones. Although the intensity of postoperative pain is low after laparoscopic surgeries, patients still experience postoperative pain. Intraperitoneal administration of some drugs can be effective for pain relief after laparoscopic surgery.
Magnesium sulfate has been reported to be effective in perioperative pain treatment and in blunting somatic, autonomic and endocrinal reflexes provoked by noxious stimuli.
As intraperitoneal instillation of MgSO4 might attenuate the hemodynamic stress response to pneumoperitoneum and improve the patient’s satisfaction by decreasing postoperative complications, this study aimed to compare the effect of early instillation of MgSO4 before any dissection on hemodynamic response and its analgesic effect versus intravenous administration of MgSO4 in patients undergoing laparoscopic mini gastric bypass.
Ojectives:
The aim of the study is to compare the efficacy of intravenous versus intraperitoneal administration of MgSO4 in pain management in laparoscopic mini gastric bypass surgery. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/12/2020 |
Actual trial start date |
05/12/2020 |
Anticipated date of last follow up |
30/12/2021 |
Actual Last follow-up date |
31/12/2021 |
Anticipated target sample size (number of participants) |
100 |
Actual target sample size (number of participants) |
100 |
Recruitment status |
Recruiting |
Publication URL |
|
|